Roberto Garcia, MD
Pathologist
About Dr. Garcia
Dr. Roberto Garcia is an Attending Pathologist with special interest and expertise in the diagnosis of neoplastic and non-neoplastic conditions of the bones, joints and soft tissues with additional experience in the field of immunohistochemistry and molecular genetics.
Dr. Garcia received his medical degree from the Instituto Tecnologico de Santo Domingo in the Dominican Republic. He trained in Anatomic and Clinical Pathology at Harlem Hospital Center followed by a Fellowship in Orthopedic Pathology at the Hospital for Joint Diseases Orthopedic Institute. He has a special interest in the education of medical students, pathology residents and fellows and orthopedic residents and fellows.
Special Expertise
Orthopedic Pathology
Surgical Pathology
Immunohistochemistry
Insurance
EmblemHealth HIP
EmblemHealth Medicare
EmblemHealth Select Care
EmblemHealth Vytra
If your insurance is not listed, please call our office if you have questions regarding your insurance coverage. If you have out-of-network benefits, then your insurance may reimburse you for a portion of your office visit. We will work with you and your insurance to minimize your out-of-pocket costs. Financial assistance may be available for patients in need.
Credentials
Appointments
Attending Pathologist, Hospital for Special Surgery
Associate Professor of Clinical Pathology and Laboratory Medicine, Weill Cornell Medical College
Certifications
Anatomic Pathology and Clinical Pathology, 1999Education
Medical: Instituto Tecnologico de Santo Domingo (INTEC), Santo Domingo, Dominican Republic, 1989
Residency: College of Physicians and Surgeons of Columbia University at Harlem Hospital Center, New York, NY, 1999
Fellowship: Hospital for Joint Diseases Orthopaedic Institute, New York, NY, 2000
State Licensure
New York
Languages
EnglishFor My Patients
Publications by Dr. Garcia
Selected Journal Articles
Ge X, Tsang K, He L, Garcia RA, Ermann J, Mizoguchi F, Zhang M, Zhou B, Aliprantis AO. NFAT restricts osteochondroma formation from entheseal progenitors. JCI Insight 2016;1(4):e86254. PMID: 27158674
Garcia RA, Demicco EG, Klein MJ, Schiller AL. Bones, Joints and Soft Tissue. In: Strayer DS, Rubin R, eds. Rubin’s Pathology: Clinicopathological Foundations of Medicine. 7th Ed. Philadelphia, PA: Wolters Kluwer Health; 2015:1305-1380.
Garcia RA, Platica CD, Greco MA, Steiner GC. Myofibroblastic differentiation of stromal cells in giant cell tumor of bone: an ultrastructural and immunohistochemical study. Ultrastruct Pathol. 2013 May;37(3):183-90. PMID: 23650991
Garcia RA, Inwards CY, Unni KK. Benign bone tumors-recent developments. Semin Diagn Pathol 2011; 28(1):73-85. PMID: 21675379
Hoch BL, Garcia RA, Smalberger GJ. Chondroid Tenosynovial Giant Cell Tumor: A Clinicopathological and Immunohistochemical Analysis of 5 New Cases. Int J Surg Pathol 2011 Apr;19(2):180-7. PMID: 21087985
Wen YH, Koeppen H, Garcia R, Chiriboga L, Tarlow BD, Peters BA, Eigenbrot C, Yee H, Steiner G, Greco MA. Epidermal growth factor receptor in osteosarcoma: expression and mutational analysis. Hum Pathol 2007 Aug;38(8):1184-91. PMID: 17509661
Guo H, Garcia RA, Perle MA, Amodio J, Greco MA. Giant cell tumor of soft tissue with pulmonary metastases: pathologic and cytogenetic study. Pediatr Dev Pathol 2005 Nov-Dec;8(6):718-724. PMID: 16328671
Research
Clinical Trials / Research Studies
Industry Relationships
HSS has a long history of supporting appropriate relationships with industry because they advance HSS's mission to provide the highest quality patient care, improve patient mobility, and enhance the quality of life for all, and to advance the science of orthopedic surgery, rheumatology, and their related disciplines through research and education.
As of May 11, 2024, Dr. Garcia reported no relationships with the healthcare industry.
HSS and its physicians make this information available to patients and the public, thus creating a transparent environment for those who are interested in this information. Further, the HSS Conflicts of Interest and Commitment Policy prohibits physicians from collecting royalties on products they develop that are used on patients at HSS.